e-Drug3D

102

BROMODIPHENHYDRAMINE

DISCONTINUED


INN
BROMODIPHENHYDRAMINE

cas 1808-12-4
CLASS

DERMATOLOGICALS
ANTIHISTAMINES
HISTAMINE H1 RECEPTOR ANTAGONIST

ROUTE (list)

ORAL

ATC code

D04AA32
R06AA02
D04AA33
R06AA52
M01AE57

PK parameters

Target

TARGET HISTAMINE H1 RECEPTOR

DrugCentral

Histamine H1 receptor UNIPROT P35367 HRH1

Download SDF file 2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine

Formula:
C17H20BrNO

Calculated chemical properties:

MW 334.24
NB_atoms 20
XLogP 4.12
PSA 14.417
NB_HD 0
NB_HA 2
fsp3 0.29
Lipinski(0=no;1=yes) 1

FDA
NDA 007984 (pdf not found) INN (BROMODIPHENHYDRAMINE HYDROCHLORIDE) AMBODRYL (PARKE DAVIS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 088343 (pdf not found) INN (BROMODIPHENHYDRAMINE HYDROCHLORIDE ; CODEINE PHOSPHATE) BROMANYL (ALPHARMA US PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 009319 (pdf not found) INN (BROMODIPHENHYDRAMINE HYDROCHLORIDE ; CODEINE PHOSPHATE) AMBENYL (FOREST LABS) APPROVAL= AP YEAR= 1954 DISCONTINUED
NDA 088626 (pdf not found) INN (BROMODIPHENHYDRAMINE HYDROCHLORIDE ; CODEINE PHOSPHATE) BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE (WOCKHARDT) APPROVAL= AP YEAR= 1984 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL